Company / Assets per Share
Haemonetics Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$48.26
FY2025
5-year range
$35.44 / $48.26
FY2021-FY2025
Trend
+10.9%
vs FY2024
Sector context
#61 of 163
Health Care
What the data says
At $48.26, Haemonetics's assets per share ranks #61 of 163 in the Health Care sector. Assets per Share has increased for 7 consecutive years, from $23.68 in FY2018 to $48.26 in FY2025.
Based on SEC 10-K filings.
48.26 in FY2025 with a 5-year CAGR of +14.3%.
Improved from $37.64 to $48.26 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +10.1%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
#61 of 163 in Health CareTop 37% of 163This company $48.26 Sector average $114.17
▼
-57.7% below sector average
Key checks
Key Insights
- Haemonetics's assets per share has grown for 7 consecutive years.
- In FY2025, assets per share increased 10.9% year-over-year.
- Ranks #61 out of 163 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $48.26 | +10.9% |
| FY2024 | $43.52 | +15.6% |
| FY2023 | $37.64 | +4.1% |
| FY2022 | $36.17 | +2.1% |
| FY2021 | $35.44 | +43.5% |
| FY2020 | $24.70 | +0.4% |
| FY2019 | $24.60 | +3.9% |
| FY2018 | $23.68 | -2.6% |
| FY2017 | $24.32 | -4.7% |
| FY2016 | $25.53 | -10.6% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026